Understanding the FDA Process Is Critical for Young Companies

Area of Science:

• Medical Technology
• Regulatory Science

Background:

• Augmented reality (AR) and virtual reality (VR) are increasingly integrated into healthcare.
• Early-stage companies developing AR/VR medical devices face regulatory hurdles.
• Lack of regulatory experience can complicate the Food and Drug Administration (FDA) clearance process.

Purpose of the Study:

• To share insights from a successful FDA 510(k) clearance process for an AR preoperative planning software.
• To guide other early-stage companies through the medical device regulatory landscape.
• To highlight key considerations for achieving efficient and successful FDA clearance.

Main Methods:

• The study describes the experience of obtaining FDA 510(k) clearance for a class 2 medical device.
• It focuses on a specific augmented reality preoperative planning software application.
• The narrative emphasizes practical lessons learned during the regulatory submission.

Main Results:

• The augmented reality preoperative planning software achieved class 2 medical device clearance via the FDA 510(k) pathway.
• The process, while new to the team, was successfully navigated.
• Key learnings were identified to facilitate future regulatory submissions.

Conclusions:

• Navigating FDA 510(k) clearance is achievable for early-stage companies with AR/VR medical devices.
• Proactive understanding of regulatory requirements is crucial for efficiency.
• Sharing experiences can demystify the process and support other innovators.